Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome

被引:27
|
作者
Sladkova, Vladimira [1 ]
Mares, Jan [1 ]
Lubenova, Blanka [1 ]
Zapletalova, Jana [1 ]
Stejskal, David [1 ]
Hlustik, Petr [1 ]
Kanovsky, Petr [1 ]
机构
[1] Univ Hosp Olomouc, Dept Neurol, Olomouc, Czech Republic
关键词
Multiple sclerosis; CIS; RRMS; CSF; Inflammatory markers; Degenerative markers; TAU-PROTEIN; AXONAL DAMAGE; CYSTATIN-C; SUBGROUPS;
D O I
10.1179/016164110X12816242542535
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Literature includes evidence of initial predominance of inflammation and later development of neurodegeneration in the pathogenesis of multiple sclerosis (MS). Objective: To search for differences in inflammatory and degenerative cerebrospinal fluid (CSF) markers between relapsing-remitting MS (RRMS) and the clinical isolated syndrome (CIS). Methods: A total of 148 subjects were evaluated, 65 MS patients (45 RRMS and 20 CIS) and 83 controls. The evaluated parameters included albumin quotient and prealbumin, transferrin, C3 and C4 complement factors, haptoglobin, beta-2-microglobulin, orosomucoid, alpha-1-antitrypsin, apolipoprotein A-I, apolipoprotein B, cystatin C, neuron-specific enolase, tau protein, beta-amyloid, oligoclonal IgG band (OCB), and IgG quotient (QIgG). Results: No differences were found in the inflammatory and degenerative CSF markers between patients with RRMS and CIS. QIgG was higher in RRMS than that in CIS but the number of OCB was higher after CIS. Cystatin C levels were significantly lower in RRMS compared to the other groups. It can be considered an indicator of the demyelination degree. Normal values of beta-amyloid were less frequent in RRMS compared to those in controls.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 50 条
  • [1] Cholesterol levels in plasma and cerebrospinal fluid in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis
    Evangelopoulos, Maria-Eleftheria
    Koutsis, Georgios
    Boufidou, Fotini
    Markianos, Manolis
    NEUROBIOLOGY OF DISEASE, 2022, 174
  • [2] Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome
    Pavelek, Zbysek
    Vysata, Oldrich
    Tambor, Vojtech
    Pimkova, Kristyna
    Dai Long Vu
    Kuca, Kamil
    Stourac, Pavel
    Valis, Martin
    BIOMEDICAL REPORTS, 2016, 5 (01) : 35 - 40
  • [3] Cerebrospinal fluid isoprostanes are not related to inflammatory activity in relapsing-remitting multiple sclerosis
    Greco, A
    Minghetti, L
    Puopolo, M
    Cannoni, S
    Romano, S
    Pozzilli, C
    Levi, G
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 224 (1-2) : 23 - 27
  • [4] Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis
    Hakansson, I.
    Tisell, A.
    Cassel, P.
    Blennow, K.
    Zetterberg, H.
    Lundberg, P.
    Dahle, C.
    Vrethem, M.
    Ernerudh, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (05) : 703 - 712
  • [5] Serum and Cerebrospinal Fluid Prolactin levels in Male and Female Patients with Clinically-Isolated Syndrome or Relapsing-Remitting Multiple Sclerosis
    Markianos, M.
    Koutsis, G.
    Evangelopoulos, M. E.
    Mandellos, D.
    Sfagos, C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2010, 22 (06) : 503 - 508
  • [6] Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis
    Alcázar, A
    Regidor, I
    Masjuan, J
    Salinas, M
    Alvarez-Cermeño, JC
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 104 (01) : 58 - 67
  • [7] Chemokines in the cerebrospinal fluid of patients with active and stable relapsing-remitting multiple sclerosis
    Moreira, MA
    Souza, ALS
    Lana-Peixoto, MA
    Teixeira, MM
    Teixeira, AL
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2006, 39 (04) : 441 - 445
  • [8] Decreased concentration of Klotho in the cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
    Aleagha, Mohammad Sajad Emami
    Siroos, Bahaadin
    Ahmadi, Mona
    Balood, Mohammad
    Palangi, Alireza
    Haghighi, Afsaneh Nazari
    Harirchian, Mohammad Hossein
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 281 : 5 - 8
  • [9] Oxylipins in cerebrospinal fluid in clinically isolated syndrome and relapsing remitting multiple sclerosis
    Hakansson, Irene
    Gouveia-Figueira, Sandra
    Ernerudh, Jan
    Vrethem, Magnus
    Ghafouri, Nazdar
    Ghafouri, Bijar
    Nording, Malin
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2018, 138 : 41 - 47
  • [10] Tau protein in cerebrospinal fluid:: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis
    Martínez-Yélamos, A
    Saiz, A
    Bas, J
    Hernandez, JJ
    Graus, F
    Arbizu, T
    NEUROSCIENCE LETTERS, 2004, 363 (01) : 14 - 17